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ABSTRACT
G-quadruplexes are nucleic acid secondary struc-
tures for which many biological roles have been
proposed but whose existence in vivo
has remained elusive. To assess their formation,
highly specific G-quadruplex ligands are needed.
Here, we tested Phen-DC3 and Phen-DC6, two
recently released ligands of the bisquinolinium
class. In vitro, both compounds exhibit high affin-
ity for the G4 formed by the human minisatellite
CEB1 and inhibit efficiently their unwinding by the
yeast Pif1 helicase. In vivo, both compounds rapidly
induced recombination-dependent rearrangements
of CEB1 inserted in the Saccharomyces cerevisiae
genome, but did not affect the stability of
other tandem repeats lacking G-quadruplex
forming sequences. The rearrangements yielded
simple-deletion, double-deletion or complex
reshuffling of the polymorphic motif units, mimicking
the phenotype of the Pif1 inactivation. Treatment
of Pif1-deficient cells with the Phen-DC compounds
further increased CEB1 instability, revealing
additional G4 formation per cell. In sharp contrast,
the commonly used N-methyl-mesoporphyrin IX
G-quadruplex ligand did not affect CEB1 stability.
Altogether, these results demonstrate that the
Phen-DC bisquinolinium compounds are potent
molecular tools for probing the formation
of G-quadruplexes in vivo, interfere with their
processing and elucidate their biological roles.
INTRODUCTION
G-quadruplexes (G4) are four-stranded nucleic acid
helical structures that spontaneously form in vitro within
certain G-rich sequences. The unitary motif of this struc-
ture is composed of four guanines stabilized by
non-canonical H-bonding in a coplanar arrangement
(called a G-quartet) (1). The uninterrupted stacking of at
least three G-quartets stabilized by monovalent cations
(Na
+ or K
+) is suﬃcient to form a G4. Quadruplexes
can result from intra-molecular folding of one DNA
strand containing four triplets of G separated by few
bases or from intermolecular association of several
strands and adopt a large variety of conformations,
depending on the size and sequence of intervening loops,
and have been documented by numerous structural studies
(2).
Evidences concerning the in vivo formation of G4 and
their involvement in several biological pathways remain
limited but are starting to emerge (3–5). Formation of
G4 in transcribed human G-rich DNA arrays in bacteria
was visualized by electron microscopy (5). In ciliates, the
formation of G4 was detected by immunochemistry (6). In
this organism, the formation of G4 is triggered by speciﬁc
telomere end-binding proteins which in turn regulates
telomere protection from degradation and
cell-cycle-dependent accessibility to telomerase (6,7).
Using genetic approaches, the formation of G4 was
shown to participate in the instability of the human
CEB1 minisatellite inserted on a yeast chromosome (8),
in a gene conversion pathway resulting in pilin antigenic
variation in the bacteria Neisseria gonorrhoeae (9), and in
the instability of guanine-rich regions in the
Caenorhabditis elegans genome in absence of the dog-1
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have provided a wealth of information concerning the
occurrence and location within the genome of sequences
having potential to form intra-molecular G4, as inferred
from their primary DNA sequence (11). These potential
G4-forming sequences are statistically over-represented at
several loci, including telomeres of most eukaryotic organ-
isms, at the rDNA loci in yeast (12) and human (13), and
are signiﬁcantly enriched in promoters sequences in
human (14), yeast (12) and in C. elegans (15). These
studies suggest that G4-DNA structures could exert a reg-
ulatory eﬀect in cis on gene expression, either by recruiting
factors at promoters or helping maintain a chromatin
organization to favor or repress transcription. Some of
these hypotheses have started to be submitted to experi-
mental challenge, but it is still unclear how much of these
potential G4 really form in vivo and how they speciﬁcally
aﬀect, for example, replication, transcription or recombi-
nation of genomic regions surrounding them.
To address the biological roles of G4, another approach
of general use is the stabilization of these structures in vivo
using speciﬁc ligands. The presence of G4-forming
sequences at human telomeres and the fact that the ﬁrst
generation of G4-binding ligands were able to inhibit
telomerase (16) have largely contributed to make G4 the
archetypal higher order nucleic acid structure for the
design of selectively targeting ligands in the presence of
duplex DNA. Among the large number of ligands
produced to date (17), the porphyrin derivatives
N-methyl-mesoporphyrin IX (NMM, Figure 1A) and
TmPyP4, and the perylene dimide derivative PIPER (18)
are commercially available and thus have been often used
for biochemical and biological studies. However, these
two porphyrins are not optimal tools for probing
quadruplex functions in vivo since NMM is selective for
G4 over duplex DNA but is a relatively low-aﬃnity ligand
(19) and TmPyP4 has a high aﬃnity but a poor selectivity
for quadruplex DNA (20,21). Equally, the propensity of
PIPER to aggregate in aqueous media (22) and its binding
to duplex DNA renders its biological use questionable.
The natural product telomestatin, which fulﬁlls both
requirements of selectivity and aﬃnity, was promising
and thus has been used to probe quadruplex structures
in vivo and in vitro (23,24). However, telomestatin suﬀers
several disadvantages such as poor water-solubility,
chemical instability, and at present is only accessible by
an arduous multi-step synthetic pathway (25) that makes
large-scale use diﬃcult. In this context, we recently
developed the bisquinolinium family of compounds that
includes Phen-DC3 and Phen-DC6 [Figure 1A, referred as
compounds 2a and 2b respectively in ref. (26)], two prom-
ising molecules that emerged for their strong quadruplex
stabilizing ability and an exquisite selectivity for
quadruplex over duplex DNA. Indeed, the G4 recognition
properties of Phen-DC3 and Phen-DC6 rival or surpass
those of the best G4-binders such as Braco-19,
telomestatin and their pyridine analogues (360A, 307A),
which all exhibit a high selectivity for G4 and an aﬃnity in
the nanomolar range (27–29). In addition, the chemical
stability and ease of preparation of our Phen-DC com-
pounds are important advantages (27).
Although the Phen-DC compounds are very promising
candidates to foster biological studies involving potential
G4-forming sequences, their in vivo eﬃciency remains to
be established (30). Therefore, we conducted in vitro and
in vivo studies in the yeast Saccharomyces cerevisiae to
assay the biological activity of the Phen-DC ligands with
respect to the formation and the processing of G4, based
on the ability of the human CEB1 minisatellite inserted in
the yeast genome to eﬃciently form G4 structures and the
ability of the yeast Pif1 helicase to resolve these structures
(8). In budding yeast, the inactivation of Pif1, but not of
other helicases, destabilizes the CEB1 tandem array and
yields recombination-dependent size variants (8).
Figure 1. Fluorescent intercalator displacement of the G-quadruplex
formed by the CEB1 motif (G4-CEB1) with Phen-DC3, Phen-DC6
and NMM. (A) Phen-DC3, Phen-DC6 and NMM structures. (B)
Schematic representation of the FID assay. (C) TO association curve
with G4-CEB1. (D) TO displacement by (ﬁlled square) Phen-DC3,
(open square) Phen-DC6 or (ﬁlled circle) NMM in presence of K
+.
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G4 structure formed by CEB1 with high aﬃnity, and
inhibit G4 unwinding by Pif1 eﬃciently and selectively.
In WT cells, Phen-DC compounds speciﬁcally induce the
instability of G4-prone CEB1 arrays, a phenomenon
further increased in Pif1-deﬁcient mutants. These results
demonstrate that the Phen-DC compounds are exquisite
molecular tools to probe the in vivo formation of G4, to
interfere with their processing, and thereof provide mech-
anistic insights.
MATERIALS AND METHODS
G-quadruplex ﬂuorescence intercalator displacement assay
The ﬂuorescence intercalator displacement (FID) assay
was performed in lithium cacodylate buﬀer solution
(10mM LiAsO2Me2) containing NaCl or KCl (100mM)
and adjusted to pH 7.2 with HCl. The ﬂuorescence spectra
were recorded with a HORIBA Jobin-Yvon Fluoromax-
3 spectroﬂuorimeter in the wavelength range from 510 to
750nm, in a 3-ml quartz cell (path length 1cm), using the
following experimental parameters: excitation wavelength,
501nm; increment, 1nm; optical slit widths, 3.0/3.0nm;
integration time, 0.1s. The ﬂuorescence spectrum of the
buﬀer solution was recorded and was systematically sub-
tracted from all following spectra. The solutions of DNA
(0.25mM) were mixed with thiazole orange (TO) (ﬁnal
concentration 0.5mM) and reference ﬂuorescence spectra
were recorded. Increasing concentrations (from 0 to 10
molar equivalents, i.e. from 0 to 2.5mM) of ligands to be
tested were then added. After a 3-min shaking and equil-
ibration period, a ﬂuorescence spectrum was recorded for
each ligand addition step. The degree of TO displacement
(percentage of ligand-induced decrease of TO ﬂuores-
cence) is calculated from the ﬂuorescence area FA as:
TODð%Þ¼100  ð FA=FA0Þ 100
where FA0 is the ﬂuorescence area of the reference
spectrum. The percentage of displacement is then plotted
as a function of the concentration of added compound.
Helicase assays
Helicase assays were carried out by incubating 100 nM of
S. cerevisiae Pif1 and 2 nM of Cy5-labeled G4 DNA or
1 nM forked DNA substrate at 35 C, in a buﬀer contain-
ing 20mM Tris pH 7.5, 50mM NaCl, 100mg/ml bovine
serum albumin, 2mM DTT, 5mM Mg
2+ and 4mM ATP,
and the indicated amount of the G4 binding ligands
Phen-DC3, Phen-DC6 or NMM. Reactions were
pre-incubated at 35 C for 10min and started by addition
of 4mM ATP. Reactions (10ml) with G4-DNA substrates
were stopped by addition of 2ml stop buﬀer (17% Ficoll,
50mM EDTA, 3mg/ml Proteinase K) and further
incubated at 35 C for 10min. Reaction products were
loaded on a 8% polyacrylamide non-denaturing gel and
resolved by electrophoresis at 4 C and 10V/cm in TBE 1X
buﬀer containing 10mM NaCl (for G4-DNA formed in
NaCl) or 10mM KCl buﬀer (for G4-DNA formed in
KCl). Reactions containing the forked DNA substrate
(10ml) were stopped by addition of 2ml of 17%
Ficoll, 50mM EDTA and 150nM unlabelled fD20
oligonucleotide. Reaction products were loaded on a
10% polyacrylamide non-denaturing gel and resolved by
electrophoresis at 4 C and 10V/cm in TBE 1  buﬀer.
Gels were scanned with a Storm PhosphorImager
(Molecular Dynamics) at 635nm and quantiﬁed using
ImageQuant software (GE Healthcare). Two independent
lots of NMM were purchased from Frontier Scientiﬁc and
assayed with similar outcome.
Yeast strains and CEB1 minisatellites
The genotypes of the S. cerevisiae strains (S288C back-
ground) used here are reported in the Supplementary
Table S1. The rad51D strain (AND1239-5C) containing
CEB1-WT-1.7 was obtained after sporulation of the
diploid obtained by crossing AND1202-11A
(CEB1-WT-1.7 pif1::KanMX) with the BY4742
rad51::KanMX strain (31). The nucleotide sequences of
the natural human CEB1-1.8 (see Supplementary Figure
S6) and the synthetic CEB1-WT-1.7 and CEB1-Gmut-1.7
minisatellites, each containing 42 motifs, have been
previously reported (8,32). The CEB1 arrays were
inserted on the yeast chromosome VIII, upstream of the
ARG4 promoter (32).
Induction of minisatellite instability
Cells taken from a fresh patch were suspended at a density
of 2 10
5cells/ml into 5ml of rich Yeast–Peptone–
Dextrose (YPD) medium containing the indicated concen-
tration of Phen-DC3 and Phen-DC6 and 1% DMSO, or in
YPD containing only 1% DMSO (control treatment).
Cells were grown for eight generations at 30 C with agi-
tation, plated as individual colonies on YPD plates and
grown at 30 C. For the induction in synthetic complete
(SC) medium with NMM and Phen-DC3, the ﬁnal con-
centration of DMSO reached in the liquid culture and in
the control treatment was 0.4%. For the NMM treatment
in SC medium, cells were grown overnight in presence of
the drug, diluted to 2 10
5 cells/ml in the same media and
grown for an additional eight generations at 30 C, thus
undergoing approximately four additional generations in
presence of the drug compared to the control condition or
the Phen-DC3 treatment.
Analysis of minisatellite instability
Colonies grown from treated cultures were inoculated in
96-well megaplaque in YPD for 24–48h at 30 C. Pools of
4–16 colonies were made right before DNA extraction.
DNA was digested with ApaI and SpeI to probe for the
CEB1 minisatellite, or with AluI to probe for the DAN4
and FLO1 minisatellites (8). Digestion products were
migrated in a 0.8% agarose–TBE 1  gel and analyzed
by Southern blot using a radiolabeled probe correspond-
ing to the minisatellite of interest. Blots were analyzed
using a Storm PhosphorImager (Molecular Dynamics)
and quantiﬁed using ImageQuant software (GE
healthcare). To account for secondary rearrangements
(occurring after plating) in the analysis, each visible
band was quantiﬁed and normalized to the mean of the
Nucleic Acids Research, 2010,Vol.38, No. 13 4339intensity of the parental bands. Bands with signal intensity
two times lower than expected for a primary
rearrangement were removed from the counting. In
numerous instances pools of colonies were depooled for
veriﬁcation and sequencing.
Additional experimental protocols are reported in
Supplementary Material and Methods.
RESULTS
Phen-DC compounds strongly bind to the G-quadruplex
form of CEB1
Our screening and initial analysis of a large series of
potential G4-binding ligands was performed with two
quadruplex-forming oligonucleotides: 22AG
[50-AG3(T2AG3)3-30] mimicking a human telomeric
sequence and TBA [50-G2T2G2TGTG2T2G2-30], the
thrombin binding aptamer sequence (27). The
bisquinolinium-dicarboxamide derivatives Phen-DC3 and
Phen-DC6 (illustrated in Figure 1A) were among the most
selective G4 ligands.
Since G4 can fold diﬀerently depending on primary
nucleotide sequence (33), we wished to evaluate the
capacity of the Phen-DC compounds to bind to the
quadruplex conformation adopted by the more complex
human minisatellite CEB1 motif used in the present study.
To this end, we folded a single-stranded oligonucleotide
representing the prevalent 39nt CEB1 repeat motif
(G4-CEB1) (8) and assayed its interaction with the
Phen-DC and NMM compounds using the G4-FID
assay (34), whose principle is illustrated in Figure 1B.
This method is based on the competitive displacement of
the ﬂuorescent intercalator probe TO by a putative G4
ligand. TO being highly ﬂuorescent when bound to
DNA and virtually non-ﬂuorescent when free in
solution, the decrease of TO ﬂuorescence as function of
increasing ligand concentration thus serves to evaluate
binding aﬃnity of the ligand for G-quadruplex DNA
(expressed as DC50: concentration required to decrease
the ﬂuorescence signal of 50%). As shown in Figure 1C,
ﬂuorimetric titration of TO by the G4-CEB1 substrate
showed a strong ﬂuorescence increase, indicating that
TO eﬃciently bound to the G4-CEB1 conformation. The
titration curve adopted a regular shape that could be ﬁtted
with a 1/1 stoichiometry model, giving a Kd value in the
micromolar range (Kd=7.1 10
 7M). This behavior as
well as the Kd value are similar to results obtained with the
TBA and the human telomeric G4-DNA (27), thereby
indicating that, in our experimental conditions,
G4-CEB1 accommodates the probe at a single site corre-
sponding to one of the two external G-quartets. The dis-
placement of the TO by Phen-DC compounds was then
examined in K
+ (Figure 1D) and Na
+ (Supplementary
Figure S1) conditions. Both Phen-DC3 and Phen-DC6
isomers display a strong ability to displace TO
(DC50=0.4–0.5mM) with complete displacement (100%
quenching) being reached at a low ligand/quadruplex ratio
(5 and 10 for Phen-DC3 and Phen-DC6, respectively).
Considering previous results obtained with the telomeric
quadruplex and the low concentration of G4-DNA
(0.25mM) used in the test, these data unambiguously
reveal a strong interaction between Phen-DC compounds
and G4-CEB1 (Figure 1D, Supplementary Figure S1). In
sharp contrast, the NMM was much less eﬃcient in
displacing TO since saturation was not reached even at
high ligand/quadruplex ratio (>40). This result indicates
that NMM exhibits a much lower aﬃnity for G4-CEB1
than our Phen-DC compounds (Figure 1D).
Phen-DC compounds speciﬁcally inhibit G4-DNA
unwinding by the Pif1 helicase in vitro
Recently, we showed that the yeast Pif1 helicase eﬃciently
unwinds the G4-CEB1 substrate (8). To investigate the
ability of the two Phen-DC derivatives to interfere with
such G4 unwinding enzymatic activities, we tested their
eﬀect on G4-CEB1 unwinding by Pif1 in vitro. The
G4-CEB1 substrates were made in two conditions: i.e. in
presence of either Na
+ or K
+ as a monovalent cation (see
Supplementary Materials and Methods) (8). This led to
intermolecular G4-CEB1 structures with diﬀerent gel
migration properties, likely corresponding to a diﬀerent
folding of the G4-DNA. As shown in Figure 2A, Pif1
eﬃciently unwound the G4-CEB1 substrates formed in
either conditions but was rapidly inhibited by low concen-
trations of Phen-DC6 [ki(K+)=250nM; ki(Na+)=300nM].
Phen-DC3 showed comparable activity (Supplementary
Figure S2).
For comparison, we also tested the inhibition of
G4-CEB1 unwinding by NMM, reported to be a potent
inhibitor of G4-DNA unwinding by the Escherichia coli
RecQ helicase and its eukaryotic homologues Sgs1 and
BLM helicases (35). Strikingly, NMM was fairly ineﬃ-
cient in inhibiting G4 DNA unwinding by Pif1. At 5mM
concentration, the unwinding of G4-CEB1 by Pif1 was
inhibited by  50% (Figure 2B). Therefore, Phen-DC com-
pounds are more eﬀective than NMM to inhibit G4-CEB1
unwinding by Pif1, a result consistent with the diﬀerence
in their respective binding ability as evaluated by the
G4-FID assay.
Next, to address the speciﬁcity of Phen-DC compounds
for G4-DNA, we tested their eﬀect on the unwinding of a
forked 20-mer double-stranded DNA (dsDNA) substrate
(fD20). Phen-DC6 had no eﬀect on fD20 unwinding by
Pif1 at concentrations up to 1mM concentration
(Figure 2A). We could not test higher concentrations of
the drug in this assay because higher concentrations of
Phen-DC6 resulted in non-speciﬁc aggregation of DNA
substrates that were not resolved in the polyacrylamide
gel, regardless of the substrate used (G4-DNA or
dsDNA). This eﬀect is reminiscent of DNA compaction
by polyamines, a situation frequently encountered with
cationic ligands (36,37). In comparison, NMM also
exhibited speciﬁcity for G4-DNA substrates since unwind-
ing of the forked substrate was not inhibited by high con-
centrations of NMM (5mM) (Figure 2B). In conclusion,
contrary to NMM, the Phen-DC compounds are active at
low concentrations as potent and speciﬁc inhibitors of
G4-CEB1 unwinding by Pif1 helicase in vitro.
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G4-prone CEB1 minisatellite
To test the eﬀect of the Phen-DC compounds in vivo and
their speciﬁcity towards G4-DNA substrates, we
examined their capacity to trigger the instability of the
G4-prone human CEB1 minisatellite inserted in the
yeast genome (38) (Figure 3A). In WT yeast cells, the syn-
thetic 1.7kb CEB1 array (CEB1-WT-1.7) composed of 42
wild-type motifs of 39nt (Figure 3B) is rather stable (8). It
is highly destabilized in the absence of the Rad27/FEN1
endonuclease or of the Pif1 helicase, but in the latter case,
only when the CEB1 repeats contains G4-forming
sequences (8). Mutation of the G4-forming motifs in the
synthetic CEB1 array (CEB1-Gmut-1.7, Figure 3B) stabi-
lizes CEB1 in pif1D cells but not in rad27D cells (8). Thus,
this system provides a well-deﬁned genetic assay to
monitor the formation of G4 structures in vivo.
We ﬁrst treated WT cells carrying the synthetic
CEB1-WT-1.7. The frequency of CEB1 instability was
measured by the appearance of size variants (expansions
or contractions) visualized by Southern blot analysis
(Figure 3C). Treatment of cells grown in rich media
(YPD) with increasing doses of Phen-DC3 or Phen-DC6
(up to 500mM and 200mM, respectively) had no eﬀect on
cell growth (Supplementary Figure S3A). In untreated
cells or upon 1% DMSO control treatment (Phen-DC
compounds are solubilized in pure DMSO), CEB1
rearrangements were rare: 2/708 and 2/384 respectively
(Table 1). In contrast, upon treatment with 200mM and
500mM of Phen-DC3, the frequency of size variants
increased to 4.2% (16/384 rearranged colonies) and
7.6% (44/576), respectively (Figure 3C, Table 1). This
dose–response was statistically signiﬁcant (P=0.029).
Similarly, treatment with 200mM Phen-DC6 also
Figure 2. Inhibition of G4-CEB1 unwinding by Phen-DC6 and NMM in vitro.( A) Pif1 unwinding of G4-CEB1 or forked DNA substrate (fD20) in
presence of increasing concentrations of Phen-DC6. The G4-CEB1 substrates were formed in presence of Na
+ or K
+ as indicated. Quantiﬁcations
(mean±SD) from three independent experiments are shown. Open triangle indicates boiled substrate. Dash indicates absence of Pif1. Position of
G4-CEB1 (G4) and unwound substrate (ss) are indicated. (B) Same as in (A), using NMM as a G4 ligand.
Nucleic Acids Research, 2010,Vol.38, No. 13 4341stimulated signiﬁcantly the formation of CEB1-WT-1.7
rearrangements to yield a frequency of 4.7% (18/384)
(Table 1), indicating that both compounds, structurally
close to each other, behave similarly and yielded
variants of diverse size. Lower concentrations of
Phen-DC were active in diﬀerent media (see below).
Again, treatment with 200mM or 500mM NMM did not
stimulate CEB1-WT-1.7 instability (Table 1,
Supplementary Figure S4). We concluded that the two
Phen-DC isomers are equally able to enter the cells and
Figure 3. Phen-DC compounds trigger G-quadruplex-dependent CEB1 instability. (A) Schematic representation of the CEB1 minisatellite insertion
in the chromosome VIII. (B) Sequences of CEB1-WT and CEB1-Gmut motifs. G-runs involved in G-quadruplex formation are boxed. Point
mutations introduced in CEB1-Gmut motif and preventing G-quadruplex formation in vitro are shown in bold. (C) Southern blot analysis of
WT cells carrying CEB1-WT-1.7 (strain AND1212-10D) or CEB1-Gmut-1.7 (AND1227-5C) after control (1% DMSO) or 500 mM Phen-DC3
treatment. The number of colonies analyzed and the rearrangement frequencies are indicated below each gel. Size markers (kb) are indicated on
the right. The position of the parental minisatellite alleles (42 repeats, 1.7kb) is indicated by an asterisk.
Table 1. Frequencies of CEB1 rearrangements in WT cells
Strain: AND1212-10D AND1227-5C
Minisatellite: CEB1-WT-1.7 CEB1-Gmut-1.7
Rearrangt. Freq. P-value versus control Rearrangt. Freq. P-value CEB1-WT-1.7
versus CEB1-Gmut-1.7
YPD media
Untreated 2/708 (0.3%)
a NS 0/192
a NS
Treatment
Control 2/384 (0.5%) NA 2/384 (0.5%) NS
Phen-DC6 200 mM 18/384 (4.7%) 3.4e
 4 1/384 (0.2%) 6.4e
 5
Phen-DC3 200 mM 16/384 (4.2%) 1.2e
 3 0/384 2.6e
 5
Phen-DC3 500 mM 44/576 (7.6%) 9.1e
 8 2/384 (0.5%) 9.1e
 8
NMM 200 mM 0/384 NS 3/368 (0.8%) NS
NMM 500 mM 0/192 NS ND NA
SC media
Treatment
Control 0/192 NA ND NA
Phen-DC3 2 mM 2/384 (0.5%) NS ND NA
Phen-DC3 20 mM 27/384 (7%) 2.4e
 5 3/384 (0.8%) 5.8e
 6
NMM 20 mM 0/384 NS ND NA
aData from ref. (8).
Rearrangement frequencies were compared using a two-tailed Fischer’s exact test.
NA, not applicable; ND, not determined; NS, not signiﬁcant.
4342 Nucleic Acids Research, 2010,Vol.38, No. 13to trigger a biological response in the nucleus, namely to
induce an 8-15 fold stimulation of CEB1 rearrangements.
Then, to test if the CEB1 instability triggered by the
Phen-DC compounds relied speciﬁcally on the formation
and/or stabilization of G4 structures, we carried out
similar experiments with cells bearing a CEB1-Gmut-1.7
array. In contrast to the CEB1-WT-1.7 array, the
CEB1-Gmut-1.7 array remained stable upon treatment
with up to 500mM Phen-DC3 or 200mM Phen-DC6
(Figure 3C, Table 1). In these conditions and in both
control experiments (untreated or incubated with 1%
DMSO), the frequencies of CEB1 rearrangements are in
the range of 0.5% or less, and are not signiﬁcantly diﬀer-
ent from each other. Also, the treatment with 200mM
NMM had no eﬀect (Table 1). To further test the
speciﬁcity of the Phen-DC compounds, we also
examined the behavior of two natural yeast minisatellites
DAN4 and FLO1, which are devoided of potential
G4-forming sequences. Neither minisatellite was
destabilized upon treatment with Phen-DC3 or
Phen-DC6 (0/384 rearrangement, at 200mM in each
case). Thus, CEB1 instability observed in WT cells upon
treatment with Phen-DC compounds depends on the
presence of G4-forming sequences, mimicking what is
observed in pif1D cells (8).
Although consistent with its weak activity in our in vitro
assays (Figure 2), the lack of eﬀect of NMM on CEB1
stability is rather surprising since a lower dose of NMM
(8mM) was reported to signiﬁcantly alter transcription of
yeast genes bearing G4-forming sequences in their
promoter regions (12). An important diﬀerence between
this study and ours is that we used rich media (YPD)
instead of SC media. Therefore, we re-examined the
dose eﬀect of NMM and Phen-DC compounds in cells
grown in SC media. We found that NMM had a mild
eﬀect on growth at 40mM. In contrast, 20mM Phen-DC3
or 8mM Phen-DC6 was suﬃcient to reduce growth up to
50% (Supplementary Figure S3B). These eﬀects were
observed whether or not the strains carried the CEB1
minisatellite (Supplementary Figure S3B). Consequently,
although we preferred to pursue our study using YPD
media and concentrations of drugs not aﬀecting cell
growth, we nevertheless examined CEB1 instability upon
drug treatment in SC media. We observed that the treat-
ment of cells with 20mM NMM did not destabilized
CEB1-WT-1.7 (0/384 rearrangement) (Table 1,
Supplementary Figure S4). At 2mM Phen-DC3,
CEB1-WT-1.7 remained stable. In contrast, upon treat-
ment with 20mM Phen-DC3, we observed 7% instability
(27/384) of CEB1-WT-1.7 and no instability of
the CEB1-Gmut-1.7 allele (3/384 rearrangements,
P=5.8e
 6) (Table 1, Supplementary Figure S5).
Altogether, these results demonstrate that the Phen-DC
molecules are active in both rich and synthetic complete
medium.
The Phen-DC compounds increase CEB1 instability in
Pif1-deﬁcient strains
The occurrence of G4-dependent CEB1 rearrangements in
treated wild-type cells revealed that some G4 stabilized by
the Phen-DC compounds escape from the unwinding
activity of Pif1. This is consistent with the observations
that these compounds inhibit G4-CEB1 unwinding by the
Pif1 helicase in vitro (Figure 2), but whether or not Pif1
remove all or a fraction of the G4 that form in CEB1
remained to be evaluated. To address this question, we
examined the frequency of CEB1-WT-1.7, CEB1-1.8 and
CEB1-Gmut-1.7 rearrangements triggered by Phen-DC3
or Phen-DC6 in the absence of Pif1 (pif1D cells) and in a
strain carrying a helicase-dead allele of PIF1 [pif1-K264A
(39)].
In our assays, the background of CEB1 rearrangements
in WT cells is low (<1%) and roughly negligible compared
to the rapid and strong eﬀect of the Phen-DC compounds
(Table 1), but this is not the case in PIF1 mutant cells, in
which the G4-prone CEB1 minisatellite is substantially
unstable [see ref. (8) and present study]. Thus, to take
into account CEB1 rearrangements which may pre-exists
before the treatment, we estimated the eﬀect of the
G4-ligands in two steps. First, we measured the frequency
of pre-existing rearrangements in the starting cell patches
and then, as in WT cells, divided the assay culture in two
samples: one being treated by the Phen-DC compounds
and the other incubated in 1% DMSO alone (control
treatment). Thus, upon subtraction of the pre-existing
events (see Supplementary Materials and Methods for
details on the procedure used for correction), we could
estimate the frequency of rearrangements generated
during the drug treatment only (eight generations). The
pif1D cultures treated with 200mM Phen-DC6 or 500mM
Phen-DC3 exhibited a high frequency of CEB1-WT-1.7
rearrangements, 20.9% and 36.8%, respectively, instead
of 12.1% in the control treatment (P-values versus
control treatment are 4.1e
 4 and 2.7e
 16, respectively)
(Figure 4, Table 2). Similarly, the frequency of CEB1-1.8
rearrangements raised from 5.2% to 12.2% (P=1.1e
 3)
and 2.7% to 7.3%, (P=5.5e
 3) in the pif1D and
pif1-K264A cells, respectively. Thus, taking into account
the pre-existing events, estimated at 9.8% (CEB1-WT-1.7)
and 2.1 % (CEB1-1.8) in pif1D cell cultures, and at 1.3%
(CEB1-1.8) in the pif1-K264A cell cultures, the treatments
yielded a 3- to 12-fold increase of CEB1 rearrangements.
Finally, as in WT cells, the Phen-DC compounds did not
stimulate instability of the CEB1-Gmut-1.7 minisatellite
(Figure 4). Altogether, the above results demonstrate
that the Phen-DC compounds are able to stimulate
CEB1 rearrangements in the presence or absence of Pif1,
and in this latter case, uncover the in vivo formation of a
higher number of G4 than in WT cells.
Sequence of CEB1 rearrangements induced by the
Phen-DC compounds in WT and Pif1 deﬁcient cells
To determine the nature of the rearrangements induced
upon Phen-DC treatment in WT and pif1D cells, we
used the naturally polymorphic CEB1-1.8 minisatellite in
which the presence of multiple base substitutions along the
42 motifs allows a precise analysis of the contribution of
the parental motifs in the sequenced size variants (32). As
for the synthetic CEB1-WT-1.7 minisatellite, the treat-
ment of WT cells grown in YPD with 500mM Phen-DC3
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 14-fold (29/768 versus 5/1824 in the untreated cells,
P=1.8e
 11) and yielded variants of diverse size. Thus,
the presence of base polymorphisms located outside the
triplets of G involved in CEB1 quadruplex formation does
not interfere with the drug target. The sequences of 14 and
13 CEB1-1.8 contractions obtained upon treatment of WT
and pif1D cells are reported in Supplementary Figure S6.
They were diﬀerent from each other. In both strains,
simple deletions with one chimerical motif, double
deletion with two chimerical motifs, and complex events
with multiple chimerical motifs and various internal
reshuﬄing of the parental polymorphic markers
occurred (Figure 5A and B), suggesting that the underly-
ing mechanisms of rearrangements were similar in WT
and pif1D cells. No de novo mutagenic events were
observed. Thus, the nature of the rearrangements
obtained after treatment with Phen-DC3 is diverse and
reﬂects the same general pattern of events as in the
untreated pif1D (8) and rad27D (32) mutants.
Phen-DC3 treatment of Pif1-deﬁcient cells yields
unusually short CEB1 rearrangements
In comparison to the rearrangements observed in the
absence of Pif1 alone, we noted that the rearrangements
produced upon treatment of Pif1-deﬁcient cells yielded a
larger number of CEB1 fragments of small size, corre-
sponding to short variants of 15 or less repeat units
(Figure 4). A comparative analysis of the size of the
CEB1-WT-1.7 and CEB1-1.8 rearrangements obtained in
pif1D or pif1-K264A cells with or without treatment is
reported in Figure 5C. Strikingly, in all cases, despite the
existence of pre-existing rearrangements, the mean size of
the rearrangements was shorter in Phen-DC3-treated
versus untreated Pif1-deﬁcient cells (P 9.6e
 3). We also
examined the size of the CEB1 variants produced in the
rad27D cells. This cell exhibits a high level of instability for
CEB1-WT-1.7 (30%) (8) and CEB1-1.8 (41/158, 25.9%)
that is comparable to the instability measured in
pif1D-treated cells (Table 2). The mean size of the CEB1
rearrangements in rad27D is much higher than in both
pif1D and pif1-K264A treated cells (P 2.2e
 2)
(Figure 5C). Hence, the increase in short alleles upon
treatment of Pif1-deﬁcient cells is not only a consequence
of a high level of instability, but rather a speciﬁc eﬀect of
Phen-DC3 treatment.
CEB1 rearrangements induced by Phen-DC compounds
depend on the homologous recombination pathway
In previous studies, we demonstrated that in rad27D and
pif1D cells the formation of CEB1 rearrangements
depends on the process of homologous recombination,
Figure 4. Treatment with Phen-DC3 increases the instability of CEB1-WT-1.7 in pif1D cells. Southern blot analysis of CEB1-WT-1.7
(AND1202-11A) or CEB1-Gmut-1.7 (AND1206-4C-D11P2) instability in pif1D cells, before and after control (1% DMSO) or 500mM Phen-DC3
treatment. Other legends are as in Figure 3.
Table 2. Frequency of CEB1 rearrangements in pif1D cells
Strain AND1202-11A AND1206-4C-D11P2 ORT4841 ORT5087-5E
Minisatellite CEB1-WT-1.7 CEB1-Gmut-1.7 CEB1-1.8 CEB1-1.8
Mutation pif1D pif1D pif1D pif1-K264A
Before treatment 81/828 (9.8%) 1/383 (0.2%)
a 4/192 (2.1%) 5/375 (1.3%)
Treatment
Control 67/552 (12.1%) ND 20/384 (5.2%) 10/375 (2.7%)
Phen-DC6 200mM 77/368 (20.9%) 0/368 ND ND
Phen-DC3 500mM 106/288 (36.8%) 0/192 41/336 (12.2%) 26/358 (7.3%)
aData from ref. (8).
ND: not determined.
4344 Nucleic Acids Research, 2010,Vol.38, No. 13Figure 5. Sequence and size of CEB1 rearrangements produced upon treatment with Phen-DC3.( A) Schematic representation of the natural
CEB1-1.8 allele and of 14 rearrangements produced upon treatment of WT cells (ORT2914) with 500mM Phen-DC3. Nucleotide sequences are
reported in Supplementary Figure S6. Chimerical motifs combining the polymorphisms of more than three parental motifs (called ‘Mix’ in
Supplementary Figure S6) are shown as a white box. Sequences of the two red motifs in C7 have not been determined. (B) Schematic representation
of 13 rearrangements produced upon treatment of pif1D cells (ORT4841) with 500mM Phen-DC3.( C) Size distribution of CEB1-WT-1.7 and
CEB1-1.8 rearrangements in WT (AND1212-10D and ORT2914), pif1D (AND1202-11A and ORT4841), pif1-K264A (ORT5087-5E) or rad27D
(AND1218-1A and ORD6713-8D) cells, with or without treatment with 500mM Phen-DC3. Datasets are from this study, except the size distribution
of rearranged CEB1-WT-1.7 alleles in rad27D cells, obtained from ref. (8) (strain AND1218-1A). The n indicates the number of variants analyzed.
The vertical gray lines indicate the size of the parental alleles. For each distribution, dark bar: median; gray bar: mean; box: distance between the ﬁrst
and third quantiles; whiskers: extreme values; white circles: outliers. P-values were obtained by comparing the samples with a Mann–Whitney–
Wilcoxon statistical test.
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RAD52 genes (8,32). Similarly, we examined the
behaviour of the CEB1-WT-1.7 array in a rad51D strain
upon treatment with 200mM Phen-DC3 (Supplementary
Figure S7). Compared to the WT strain (4.2%
rearrangements, Table 1), we observed no rearrangements
(0/384) in the absence of Rad51 (P=2.6e
 5). Therefore,
Phen-DC treatment also leads to CEB1 rearrangements
through the homologous recombination pathway.
DISCUSSION
In this study, we investigated the in vitro and in vivo
activities of two very potent G4 ligands: Phen-DC3 and
Phen-DC6. Based on in vitro biophysical and biochemical
criteria, they are best ranked among current G4 ligands
(26,27,29,30,40) and these promises clearly extend to their
biological activity. We reported that the Phen-DC com-
pounds: (i) exhibit a strong aﬃnity for preformed
G4-CEB1 structures in vitro, (ii) inhibit the unwinding
by Pif1 of the resulting G4-ligand structure(s), (iii)
manifest biological activity in intact yeast cells, (iv)
destabilize the G4-prone but not the G4-mutated CEB1
array in WT cells, (v) further destabilize CEB1 in Pif1
deﬁcient cells, (vi) induce recombination-dependent
CEB1 size variants (expansions and contractions) similar
to the spontaneous rearrangements produced in the
absence of Pif1, and (vii) unexpectedly yield short size
CEB1 variants. Thus, as hoped, the two Phen-DC com-
pounds behave as potent biological drugs targeting G4
structures and interfering with their processing. To
choose between the Phen-DC3 and Phen-DC6 molecules,
the diﬀerences are subtle. Both are chemically stable, easy
to prepare in large amounts (27), and qualitatively their
in vitro and in vivo eﬀects are similar as expected from their
closely related chemical structures. The advantage of
Phen-DC3 is a slightly higher solubility in buﬀered solu-
tions, allowing the use of higher drug concentrations in
culture media.
To be optimal, a ligand should exhibit high selectivity
and aﬃnity for its substrate. Convincingly, the two
Phen-DC derivatives fulﬁll both requirements. They bind
with high aﬃnity to various types of G-quadruplexes
(27,40) and to the human minisatellite G4-CEB1
(Figure 1). This binding behavior is attributed to the
crescent shape and the size of the Phen-DC scaﬀold that
ﬁt with the dimensions of a G-quartet, both features being
favorable to an optimal p-overlap between the two
aromatic surfaces (26).
We extensively compared the eﬀects of the Phen-DC
compounds to NMM, a molecule previously reported to
bind G4 (19,41,42), to inhibit their unwinding by RecQ
(43), Sgs1, and BLM (35) helicases in vitro, and to exert
G4-related biological eﬀects in budding yeast (12) and
N. gonorrhoeae (9). Thus, we expected to observe an
eﬀect of NMM in our assays. The Phen-DC compounds
act at nanomolar concentrations (Ki=250 nM in K
+)
as speciﬁc inhibitors of G4-CEB1 unwinding by Pif1
in vitro (Figure 2), which is a very active helicase on
these substrates (8). In contrast, although our in vitro
experiments conﬁrmed that NMM is a selective G4
ligand (as assessed by FID), it is ineﬃcient in inhibiting
the Pif1 helicase over a wide range of concentrations
(Figure 2) and does not induce any CEB1 instability in
yeast (Table 1, Supplementary Figure S4). The low aﬃnity
of NMM for G4-CEB1 structures can explain the
discrepancies observed between treatment with NMM
and Phen-DCs. An alternative and not mutually exclusive
interpretation is that these molecules could recognize dif-
ferent G4 topologies and/or creates distinct G4-ligand
structures, which would be diﬀerently processed by Pif1
or other endogenous helicases. Along these lines, the
examination of the sequence of CEB1 motifs as well as
their organization in a direct tandem array (placing all
G triplets on the same strand) suggest that the CEB1
minisatellite has the potential to form topologically
distinct intra- and inter-motifs G4 structures with hetero-
geneous loop sizes (11). Structurally, these two
quinolinium rings, which display a pronounced
electron-acceptor character that contributes to the
increased stacking interactions with guanines, have the
potential to recognize various types of G4 via stacking
on the external quartets terminating the quadruplex
core. Thus, we envisage that the Phen-DC compounds
may have a large spectrum of G4-structure targets
(27,29,30), whereas NMM might be more speciﬁc of
certain G4 structures (41).
The instability observed in treated wild type cells and its
increase when Pif1 activity is compromised (revealing a
higher number of G4) suggest that Pif1 greatly limits the
eﬀect of these G4 ligands in vivo. Mechanistically, this can
be due to the unwinding of only a fraction of G4-CEB1 by
Pif1 in vivo. In addition to the thermodynamic shift
toward the folded state in presence of the ligand, which
could trigger the formation and/or stabilization of G4
structures that would otherwise not stably form naturally,
the persistency of G4 can be due to the inhibition of other
potential G4-processing helicases. In S. cerevisiae, Sgs1
and Dna2 were reported to exhibit a G4-unwinding
activity in vitro (44,45) but their in vivo activity on G4
substrates have not been demonstrated. We know that
the absence of Sgs1 does not stimulate CEB1 instability,
and that the deletion of the DNA2 gene in a pif1D strain
has the same eﬀect as the inactivation of Pif1 alone (8).
Further studies will be undertaken to decipher redundant
and overlapping G4 processing pathways in wild-type,
single and multi-mutant contexts.
The structure of the CEB1 rearrangements produced in
Phen-DC treated and untreated pif1D and rad27D cells are
of similar types, including simple deletion, double dele-
tions and a majority of complex events. They are inter-
preted to be the consequence of the repair of an initiating
lesion through the homologous recombination pathway,
in which multiple cycles of misaligned synthesis-dependent
strand annealing (SDSA) (46) reactions generate the
various reshuﬄing of the parental minisatellite (8,32)
[see illustration Figure 6 in ref. (32)]. However, we noted
that the CEB1-WT-1.7 rearrangements obtained in the
pif1D-treated cells were unusually short, suggesting that
the Phen-DC treatment was not exactly mimicking the
untreated situations. To confront this unexpected
4346 Nucleic Acids Research, 2010,Vol.38, No. 13observation, we made a comparative analysis of the size of
the CEB1-WT-1.7 and CEB1-1.8 rearrangements obtained
in the pif1D and the pif1-K264A mutants with or without
treatment. Strikingly, in all pairwise comparisons of
strains with the same genotype, the rearranged variants
were shorter in the treated sample (Figure 5C). Why
does the treatment of Pif1-deﬁcient cells yield extensive
contractions? An attractive possibility is that the concom-
itant formation (47) and the persistency of several G4 on
the same strand may cause multiple distant lesions
favoring large internal deletions. Mechanistically, these
mutagenic events may be reminiscent of the deletions of
G4-prone sequences reported in C. elegans mutated for the
FANC-J helicase homolog dog-1 (10). The lesion initiating
the CEB1 rearrangements could be a single-strand
nick occurring within the G4-prone region as observed
in N. gonorrhoeae (9), or a single-strand gap or a
double-strand break resulting from the persistency of
unprocessed intra-molecular G4 accumulating in CEB1
during replication, transcription or other biological pro-
cesses generating single-stranded DNA.
To conclude, the present study demonstrates that the
Phen-DC3 and Phen-DC6 bisquinolinium compounds are
reliable and potent small molecules to speciﬁcally target
and trigger a G-quadruplex-dependent biological process,
namely tandem-repeat instability. The independent and
combinatorial use of genetic and chemical interfering
approaches provides new perspectives to probe the
G4-forming sequences in yeast and other organisms (11).
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